Stopping cannabis use entirely is the only known cure for cannabinoid hyperemesis syndrome (CHS). Everything else, from hot showers to emergency room medications, manages the symptoms of an acute episode without preventing the next one. That distinction matters because people with CHS often cycle through dozens of ER visits before getting the right diagnosis, and even then, accepting the cure can feel harder than enduring the episodes.
What a CHS Episode Looks Like
CHS follows a recognizable pattern. You feel fine for days or weeks between episodes, then get hit with severe nausea, intense abdominal pain, and relentless vomiting that can last hours to days. The vomiting is often described as uncontrollable, and it does not respond well to the standard anti-nausea medications that work for most other causes. Hot showers or baths bring temporary relief, which is one of the most distinctive features of the syndrome and a strong diagnostic clue. This pattern of cyclic vomiting, chronic cannabis use, and symptom improvement with hot bathing is part of the formal diagnostic criteria.1PubMed Central. Cyclic Vomiting Syndrome Versus Cannabinoid Hyperemesis Syndrome
CHS can look a lot like cyclic vomiting syndrome (CVS), which is essentially the same symptom pattern without the cannabis connection. Distinguishing between the two matters because the treatment paths diverge completely. One study comparing pediatric and young adult patients found that those with CHS were more likely to show signs of dehydration, including lower potassium levels and higher creatinine, likely because of the combination of nonstop vomiting and prolonged hot-water bathing.2PubMed. Distinguishing Clinical Features of Cannabinoid Hyperemesis Syndrome and Cyclic Vomiting Syndrome: A Retrospective Cohort Study
Why Hot Showers Feel Like the Only Relief
Almost everyone with CHS discovers on their own that hot showers or baths help. Some people spend hours in the shower during an episode, running through their home’s hot water supply. The compulsion is strong enough that it is considered a hallmark of the condition. The reason appears to involve a receptor called TRPV1, which responds to both heat and capsaicin, the compound that makes chili peppers burn. Chronic, heavy THC exposure seems to disrupt normal TRPV1 function in the gut and brain. Hot water activates the same receptors through the skin, temporarily compensating for the disruption and restoring some normal signaling in the areas that control nausea and gastric motility.3PubMed Central. Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin
The thermoregulatory role of the endocannabinoid system may also play a part. Chronic cannabis use can shift your body’s temperature regulation, and hot water may counteract that shift in a way that calms the vomiting reflex.4PubMed Central. Cannabinoid hyperemesis relieved by compulsive bathing The relief is real but temporary. It wears off soon after you leave the shower, and the hours of hot-water exposure carry their own risks.
Topical Capsaicin as an Acute Treatment
If hot water helps because it activates TRPV1 receptors in the skin, then applying capsaicin cream directly to the abdomen should do the same thing without the need to stand in a shower for hours. That is exactly what the evidence supports. Capsaicin cream, typically the over-the-counter kind used for arthritis or nerve pain, applied to the upper stomach area has provided dramatic relief in case reports, sometimes within hours.5PubMed Central. Topical Capsaicin for Treating Cannabinoid Hyperemesis Syndrome
The mechanism is essentially the same as the hot shower: capsaicin binds to TRPV1 receptors in the skin, triggering a cascade of downstream effects that modulate nausea pathways. But it lasts longer than a shower and does not carry the dehydration risk. Around twenty documented cases had reported successful use of topical capsaicin for CHS episodes as of an early review, and the treatment has gained wider recognition since.6PubMed. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment The burning sensation on the skin can be unpleasant, but most people with active CHS episodes find it a welcome trade-off. You apply it to the epigastric region, the area between your belly button and the bottom of your rib cage, and leave it in place. Standard concentrations (0.025% to 0.1%) are what most reports have used.
What Works in the Emergency Room
If you end up in the ER during a CHS episode, the medications that work best are not the ones typically given first. Ondansetron, which is the go-to anti-nausea drug for most causes of vomiting, tends to disappoint in CHS. A randomized trial comparing intravenous haloperidol to ondansetron found that haloperidol was clearly better, producing greater improvements in both nausea and pain. Patients who received haloperidol also needed fewer rescue medications and left the ER roughly two and a half hours sooner on average.7PubMed. Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial
A systematic review of the available pharmacologic evidence found that benzodiazepines, haloperidol, and capsaicin were the treatments most frequently reported as effective for acute CHS episodes. For longer-term symptom prevention between episodes, tricyclic antidepressants showed the most promise, though the evidence base was limited to small studies and case series.8PubMed. Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review This does not mean standard anti-nausea drugs never help at all, but they tend to provide less relief than you would expect for someone vomiting that severely. The reason likely traces back to the TRPV1 disruption: the nausea in CHS is driven by a different mechanism than the nausea caused by chemotherapy, food poisoning, or motion sickness, so drugs designed for those conditions miss the target.
Intravenous fluids are a critical part of ER treatment regardless of which anti-nausea approach is used. The combination of severe vomiting and prolonged hot-water bathing puts people with CHS at high risk of dehydration and kidney injury. One study described this pattern as so common and distinct that it proposed giving it a specific name, noting that the pairing of intractable vomiting with hours of hot showers creates a perfect setup for prerenal failure.9PubMed. Cannabinoid hyperemesis acute renal failure: a common sequela of cannabinoid hyperemesis syndrome
Why CHS Can Turn Dangerous
Most people think of CHS as miserable but not life-threatening. In the vast majority of cases, that is true. But severe episodes can kill. A forensic report documented the deaths of three young adults, all in their late twenties or early thirties, with histories consistent with CHS. All had presented to emergency departments with nausea and vomiting in the days before their deaths and were treated symptomatically. The cause of death in two of the three cases was attributed to CHS.10PubMed. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases Deaths from CHS remain rare, but the cases underscore that prolonged, untreated vomiting can lead to dangerous electrolyte imbalances and dehydration, especially when compounded by hours of hot-water exposure that accelerates fluid loss through sweat.
The Only Actual Cure
Every treatment discussed so far is about managing an acute episode. The only intervention that prevents future episodes is stopping cannabis. A systematic review that pooled data across the available literature concluded that cannabis cessation is the best treatment for CHS, with resolution of the cyclic vomiting pattern following sustained abstinence.11PubMed Central. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review There is no medication that prevents CHS episodes while you continue using cannabis. No dose adjustment, strain switch, or route of administration change has been shown to reliably stop the cycle.
How long it takes for symptoms to fully resolve after quitting varies. Some people feel better within days. Others report lingering nausea for weeks. The episodes themselves typically stop once cannabis clears the system, but the timeline depends on how much fat-stored THC your body is still releasing. Heavy, long-term users may take longer to reach full resolution.
CBD Products Are Not a Safe Workaround
A common assumption is that CHS is caused specifically by THC, so switching to CBD-only products should be safe. At least one documented case challenges that thinking. A patient who had stopped cannabis but continued daily CBD use experienced recurring CHS-like episodes of abdominal pain and vomiting over six months, despite complete abstinence from THC-containing cannabis.12PubMed. Cannabinoid Hyperemesis Syndrome Presumed Secondary to CBD Use: A Case Report
The pharmacology offers a possible explanation. THC, CBD, and a lesser-known cannabinoid called cannabigerol (CBG) all interact with the emesis response, but in opposing ways.13PubMed Central. Cannabinoid hyperemesis syndrome CBD at low doses has antiemetic (anti-nausea) properties, but at higher doses it may paradoxically promote nausea. CBG, which is present in varying concentrations depending on the cannabis product, can counteract CBD’s antiemetic effects. The interplay between high-dose CBD and CBG’s action at serotonin receptors is one proposed pathway for how CHS episodes could be triggered without much THC involvement.14Medical Cannabis and Cannabinoids. Cannabinoid Hyperemesis The bottom line for anyone trying to manage CHS while still using some form of cannabis product: the evidence, though limited, suggests that CBD alone can be enough to keep the cycle going.
Why People Resist the Diagnosis
One of the most frustrating aspects of CHS, from a clinical perspective, is how often patients reject the diagnosis or refuse the only effective treatment. A qualitative study exploring this found that people with CHS had deeply positive perceptions of cannabis that made the diagnosis feel impossible to accept. Many believed cannabis was actually helping their nausea rather than causing it. Others suspected the diagnosis was part of broader medical stigmatization of cannabis use. Some tried to work around the recommendation to quit by switching to different strains, changing how they consumed cannabis, reducing frequency, or using only certain types of products.15PubMed. Contesting Cannabinoid Hyperemesis Syndrome: How Narratives of Cannabis Shape Diagnosis Contestation and Treatment Resistance
This resistance creates a painful feedback loop. Cannabis is used to treat the nausea it is causing, which temporarily masks the underlying problem while guaranteeing the next episode. It is worth understanding this dynamic without judgment: for many people, cannabis has genuinely helped with other health issues, and being told that the same substance is now making them violently ill feels contradictory. But the pattern in the medical literature is consistent. Episodes continue as long as cannabis use continues, regardless of the form or amount.
The Underlying Mechanism
CHS is fundamentally a disorder of the endocannabinoid system that develops after prolonged, heavy exposure to THC. Chronic high-dose THC acts on CB1 receptors throughout the body, and over time, this changes how the endocannabinoid system regulates several important processes: stress responses, thermoregulation, gut motility, and the TRPV1 receptor system involved in pain and nausea signaling.16PubMed Central. Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms The specific chain of events that tips someone from “heavy cannabis user without symptoms” to “CHS patient” is still not fully worked out. The TRPV1 pathway is the leading candidate, which is why activating those same receptors through heat or capsaicin provides temporary relief, but it is probably not the whole story.
Not everyone who uses cannabis heavily develops CHS, which has led researchers to look for genetic factors. A genomic study found that CHS patients were significantly more likely to carry certain gene variants, including mutations in the gene encoding the TRPV1 receptor itself, as well as variants in genes involved in dopamine signaling and drug metabolism.17PubMed Central. Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation This suggests that CHS may require both the environmental trigger (chronic heavy cannabis use) and an underlying genetic susceptibility. The research is still early, but it helps explain why your friend can use cannabis daily for a decade with no problems while you develop CHS after a few years.
The Pesticide Myth
A popular theory in online cannabis communities holds that CHS is not really caused by cannabis itself but by pesticides, neem oil, or other contaminants on improperly grown cannabis. The idea is appealing because it preserves the belief that cannabis is harmless and shifts blame to cultivation practices. But the evidence does not support it. A survey-based study found that the source of cannabis products, whether from a licensed dispensary or the black market, did not affect CHS presentation. CHS was most strongly associated with long-term, frequent use of inhaled THC-dominant cannabis regardless of where it came from.18PubMed. Cannabinoid Hyperemesis Syndrome-A Survey-Based Approach to Understanding Symptoms and Cannabis Use Patterns A separate review directly addressed and refuted the pesticide and neem oil hypotheses, pointing instead to genetic susceptibility to cannabis itself as the relevant factor.19PubMed Central. Cannabinoid hyperemesis syndrome: genetic susceptibility to toxic exposure
The Cost of Getting It Wrong
CHS is frequently misdiagnosed, and the consequences go beyond continued suffering. One study tracking seventeen patients found they averaged nearly eighteen ER visits before receiving a CHS diagnosis, with some visiting up to 38 times. The combined cost of those ER trips and the imaging studies ordered during them averaged roughly $77,000 per patient, with the highest individual total exceeding $210,000.20PubMed Central. Emergency Department and Radiological Cost of Delayed Diagnosis of Cannabinoid Hyperemesis Many of those visits involve CT scans, endoscopies, and lab panels searching for other explanations for the vomiting. The costs accumulate rapidly when a diagnosis that could be made with a careful history is instead pursued through imaging and procedures.
A broader analysis of healthcare utilization confirmed that CHS patients consume considerably more healthcare resources than comparable patients without the syndrome, driven largely by repeated evaluations that could be avoided with earlier recognition. Detailed social history-taking, especially asking directly about cannabis use patterns, is the single most important step in cutting through the diagnostic delay.21PubMed Central. Prevalence of cannabinoid hyperemesis syndrome and its financial burden on the health care industry
Rising Cases After Cannabis Commercialization
As cannabis has become legal in more places, CHS cases have climbed. But the relationship between legalization and CHS is more specific than you might expect. A study from Ontario, Canada, found that legalization alone was not associated with a change in CHS-related ER visits. The jump came later, when commercial retail sales began, which coincided with the COVID-19 pandemic period and was associated with a roughly 49% increase in CHS visit rates.22JAMA Network Open. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada In Colorado, increases in recreational dispensary density within a county were linked to increases in vomiting-related ER visits, though counties that already had established medical dispensaries before recreational legalization saw a slower rate of increase.23JAMA Network Open. Changes in Emergency Department Encounters for Vomiting After Cannabis Legalization in Colorado
Commercialization brings easier access, higher-potency products, and concentrates that deliver far more THC per use than the cannabis available a generation ago. The connection between heavier THC exposure and CHS risk is consistent with the pharmacological picture: the syndrome develops from chronic, high-dose CB1 receptor stimulation, and modern cannabis products deliver exactly that. If you use cannabis and have experienced unexplained bouts of severe nausea and vomiting, especially if hot showers help, it is worth raising CHS with your doctor before undergoing another round of imaging.